Skip to main content
SpringerLink
Log in

Patologie del sistema nervoso vegetativo

  • Chapter
Terapia delle malattie neurologiche

  • 1075 Accesses

Riassunto

I disturbi della sudorazione comprendono l’iperidrosi, caratterizzata da esagerato incremento dell’attività sudoripara, l’ipoidrosi e l’anidrosi, nelle quali si verifica una patologica riduzione o assenza della secrezione ghiandolare.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 39.95
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliografia

  1. Low PA. Sudomotor function and dysfunction. In:AK Asbury, GM McKhann, WI McDonald (eds). Diseases of the nervous system. 2nd. Philadelphia: WB Saunders Company; 1992:479–489.

    Google Scholar 

  2. Low PA, Polinsky RJ, Kaufmann HC et al. Autonomic function and dysfunction. Continuum 1998; 4 (2):18–19.

    Google Scholar 

  3. Low PA. Evaluation of sudomotor function. Clin Neurophysiology 2004; 115:1506–1513.

    Article  Google Scholar 

  4. Sato K, Kang WH, Saga K, Sato KT. Biology of sweat glands and their disorders. II. Disorders of sweat gland function. J Am Acad Dermatol 1989; 20:713–726.

    Article  CAS  PubMed  Google Scholar 

  5. Leung AKC, Chan PYH, Choi MCK.. Hyperhidrosis. Intern J Dermatol 1999; 38:561–567.

    Article  CAS  Google Scholar 

  6. Fealey RD. Thermoregulatory sweat test. In:Daube JR (ed). Clinical neurophysiology. Philadelphia: FA Davis Company; 1996:396–402.

    Google Scholar 

  7. Hoeldtke RD, Davis KM, Hshieh PB et al. Autonomic surface potential analysis:assessment of reproducibility and sensitivity. Muscle Nerve 1992; 15:926–931.

    Article  CAS  PubMed  Google Scholar 

  8. Atkins JL, Butler PEM. Hyperhidrosis:a review of current management. Plast Reconstr Surg 2002; 110:222–228.

    Article  PubMed  Google Scholar 

  9. Hashmonai M, Kopelman D, Assalia A. The treatment of primary palmar hyperhidrosis: a review. Surg Today 2000; 30:211–218.10 Freeman R, Waldorf HA, Dover JS. Autonomic neurodermatology (Part II):disorders of sweating and flushing. Semin Neurol 1992; 12:394–407.

    Article  CAS  PubMed  Google Scholar 

  10. Naumann M. Evidence-based medicine:botulinum toxin in focal hyperhidrosis. J Neurol 2001; 248 (Suppl 1):31–33.

    Article  CAS  PubMed  Google Scholar 

  11. Saadia D, Voustianiouk A, Wang AK et al. Botulinum toxin type A in primary palmar hyperhidrosis. Neurology 2001; 57:2095–2099.

    CAS  PubMed  Google Scholar 

  12. Swash M, Mathers S. Sphincter disorders and the nervous system. In: Aminoff MJ (ed). Neurology and general medicine. The neurological aspects of medical disorders. New York: Churchill Livingstone; 1995:521–539.

    Google Scholar 

  13. Fowler CJ, Betts CD, Fowler CG. Bladder dysfunction in neurologic disease. In: Asbury AK, McKhann GM, McDonald WI (eds). Diseases of the nervous system. 2nd. Philadelphia: WB Saunders Company, 1992:512–528.

    Google Scholar 

  14. Gosling JA, Dixon JS, Humpherson JA (eds). Functional anatomy of the urynary tract:an integrated text and colour atlas. Edinburgh: Churhill Livingstone, 1987.

    Google Scholar 

  15. De Groat WC. Central neural control of the lower urinary tract. In:Bock G, Whelan J (eds). Neurobiology of incontinence. Wiley, Chichester; 1990:27–42.

    Google Scholar 

  16. Fowler CJ. Neurological disorders of micturition and their treatment. Brain 1999; 122:1213–1231.

    Article  PubMed  Google Scholar 

  17. Fowler CJ. Neurological causes of bladder, bowel, and sexual dysfunction. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD (eds). Neurology in clinical practice. The neurological disorders. Woburn: Butterworth-Heinemann; 2000:429–438.

    Google Scholar 

  18. Goyal RK, Hirano I. The enteric nervous system. N Engl J Med 1996; 334:1106–1115.

    Article  CAS  PubMed  Google Scholar 

  19. Ventimiglia B, Patti F, Reggio E et al. Disorders of micturition in neurological patients:a clinical study of 786 patients. J Neurol 1998; 245:173–177.

    Article  CAS  PubMed  Google Scholar 

  20. Sakakibara R, Hattori T, Yasuda K et al. Micturitional disturbance and the pontine tegmental lesion: urodynamic and MRI analyses of vascular cases. J Neurol Sci 1996; 141:105–110.

    Article  CAS  PubMed  Google Scholar 

  21. Joseph PA, De Sèze M. Les troubles génito-sphinctériens. Rev Neurol (Paris) 2001; 8–9:1051–1059.

    Google Scholar 

  22. Sakakibara R, Hattori T, Tojo M et al. Micturitional disturbance in myotonic distrophy. J Auton Nerv Syst 1995; 52:17–21.

    Article  CAS  PubMed  Google Scholar 

  23. Blaivas JG, Chaikin DC, Chancellor MB et al. Neurourology. Continuum 1998; 4 (4):43–53.

    Google Scholar 

  24. Fowler CJ. Investigation of the neurogenic bladder. J Neurol Neurosurg Psychiatry 1996; 60:6–13.

    Article  CAS  PubMed  Google Scholar 

  25. Romero Y, Evans JM, Fleming KC et al. Constipation and fecal incontinence in the elderly population. Mayo Clin Proc 1996; 71:81–92.

    Article  CAS  PubMed  Google Scholar 

  26. Webb RJ, Lawson AL. Clean intermittent self-catheterisation in 172 adults. Br J Urol 1990; 65:20–23.

    Article  CAS  PubMed  Google Scholar 

  27. Thuroff JW, Bunke B, Ebner A et al. Randomized, double blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo. J Urol 1991; 145:813–816.

    CAS  PubMed  Google Scholar 

  28. Abrams P, Freeman R, Anderstrom C et al. Tolterodine, new antimuscarinic agent; as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br J Urol 1998; 81:801–810.

    CAS  PubMed  Google Scholar 

  29. Delaere KPJ, Michiels HE, Debruyne FMJ et al. Flavoxate hydrochloride in the treatment of detrusor instability. Urol Int 1977; 32:377–381.

    Article  CAS  PubMed  Google Scholar 

  30. Cardozo L, Lisec M, Millard R, et al. Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J Urol 2004; 172:1919–1924.

    Article  CAS  PubMed  Google Scholar 

  31. Haab F, Stewart L, Dwyer P. Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder. Eur Urol 2004; 45:420–429.

    Article  CAS  PubMed  Google Scholar 

  32. Foote J, Glavind K, Kralidis G et al. Treatment of over-active bladder in the older patient:pooled analysis of three phase III Studies of Darifenacin, an M3 selective Rreceptor antagonist. Eur Urol 2005; 48:471–477.

    PubMed  Google Scholar 

  33. Abrams P, Swift S. Solifenacin is effective for the treatment of OAB dry Ppatients:a pooled analysis. Eur Urol 2005; 48:483–487.

    CAS  PubMed  Google Scholar 

  34. DuBeau CE, Khullar V, Versi E. Unblinding in randomized controlled drug trials for urinary incontinence: Implications for assessing outcomes when adverse effects are evident. Neurourol Urodyn 2005; 24:13–20.

    Article  PubMed  Google Scholar 

  35. Fowler CJ, Beck RO, Gerrard S et al. Intravescical capsaicin for the treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry 1994; 57:169–73.

    Article  CAS  PubMed  Google Scholar 

  36. Cruz F, Guimaraes M, Silva C et al. Suppression of bladder hyperreflexia by ointravescical resiniferatoxin. Lancet 1997; 350:340–341.

    Article  Google Scholar 

  37. Lazzeri M, Spinelli M, Zanollo A et al. Intravesical vanilloids and neurogenic incontinence:ten years experience. Urol Int 2004; 72:145–149.

    Article  PubMed  Google Scholar 

  38. Watanabe T, Yokoyama T, Sasaki K, et al. Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity. Int J Urol 2004; 11:200–205.

    Article  CAS  PubMed  Google Scholar 

  39. Silva C, Silva J, Ribeiro MJ, et al. Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin:results of a double-blind randomized placebo-controlled trial. Eur Urol 2005.

    Google Scholar 

  40. Reynard JM. Does anticholinergic medication have a role for men with lower urinary tract symptoms/ benign prostatic hyperplasia either alone or in combination with other agents? Curr Opin Urol 2004; 14:13–16.

    Article  PubMed  Google Scholar 

  41. Sahai A, Khan M, Fowler CJ, Dasgupta P. Botulinum toxin for the treatment of lower urinary tract symptoms:a review. Neurourol Urodyn 2005; 24:2–12.

    Article  CAS  PubMed  Google Scholar 

  42. Jost WH, Naumann M. Botulinum toxin in neuro-urological disorders. Mov Disord 2004; 19 (Suppl 8):S142–S145.

    Article  PubMed  Google Scholar 

  43. -Cruz F, Silva C. Botulinum toxin in the management of lower urinary tract dysfunction:contemporary update. Curr Opin Urol 2004; 14:329–334.

    Article  PubMed  Google Scholar 

  44. Reitz A, Stohrer M, Kramer G, et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004; 45:510–515.

    Article  CAS  PubMed  Google Scholar 

  45. Barnes DG, Shaw PJ, Timoney AG et al. Management of the neuropathic baldder by soprapubic catheterisation. Br J Urol 1993; 72:169–172.

    CAS  PubMed  Google Scholar 

  46. Dijkema HE, Weil EH, Mijs PT et al. Neuromodulation of sacral nerves for incontinence and voiding dysfunctions. Clinical results and complications. Eur Urol 1993; 24:72–76.

    CAS  PubMed  Google Scholar 

  47. Brindley GS. The first 500 patients with sacral anterior root stimulator implants:general description. Paraplegia 1994; 32:795–805.

    CAS  PubMed  Google Scholar 

  48. Fowler CJ. Neurourology. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD (eds). Neurology in clinical practice. The neurological disorders. Woburn: Butterworth-Heinemann; 2000:743–57.

    Google Scholar 

  49. Rubin G. Constipation. Clin Evid 2002; 7:292–296.

    PubMed  Google Scholar 

  50. Aminoff MJ. Postural hypotension. In: Aminoff MJ (ed). Neurology and general medicine. The neurological aspects of medicine disorders. New York: Churchill Livingstone; 1995:137–158.

    Google Scholar 

  51. Wieling W, Cortelli P, Mathias CJ. Treating neurogenic orthostatic hypotension. In: Appenzeller O (ed). Handbook of clinical Neurology. Vol 75:The autonomic nervous system. Part II. Dysfunctions. Amsterdam: Elsevier Science; 2000:714–729.

    Google Scholar 

  52. Tuck RR; McLeod JG. Vasomotor function and dysfunction. In: AK Asbury, GM McKhann, WI McDonald (eds). Diseases of the nervous system. 2nd. Philadelphia: WB Saunders Company; 1992:469–478.

    Google Scholar 

  53. Stewart JM. Orthostatic intolerance in pediatrics. J Pediatr 2002; 140:404–411.

    Article  PubMed  Google Scholar 

  54. Smit AA, Halliwill JR, Low PA et al. Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol 1999; 519:1–10.

    Article  CAS  PubMed  Google Scholar 

  55. Freeman R. Neurogenic Orthostatic Hypotension. N Engl J Med 2008;358:615–624.

    Article  CAS  PubMed  Google Scholar 

  56. Robertson D, Kincaid DW, Haile V et al. The head and neck discomfort of autonomic failure:un unrecognized aetiology of headache. Clin Auton Res 1994;4:99–103.

    Article  CAS  PubMed  Google Scholar 

  57. Gibbons CH, Freeman R. Orthostatic dyspnea:a neglected symptom of orthostatic hypotension. Clin Auton Res 2005; 15:40–44.

    Article  PubMed  Google Scholar 

  58. Thaisetthawatkul P, Boeve BF, Benarroch EE et al. Autonomic dysfunction in dementia with Lewy bodies. Neurology 2004; 62:1804–1809.

    CAS  PubMed  Google Scholar 

  59. Low PA, Bnerud-Larson LM, Sletten DM et al. Autonomic symptoms and diabetic neuropathy:a population-based study. Diabetes Care 2004; 27:2942–2947.

    Article  PubMed  Google Scholar 

  60. Rudnicki SA, Dalmau J. Paraneoplastic syndromes of the peripheral nerves. Curr Opin Neurol 2005; 18:598–603.

    Article  PubMed  Google Scholar 

  61. Vernino S, Low PA, Fealey RD et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000; 343:847–855.

    Article  CAS  PubMed  Google Scholar 

  62. Wright RA, Grant IA, Low PA. Autonomic neuropathy associated with sicca complex. J Auton Nerv Syst 1999; 75:70–6.

    Article  CAS  PubMed  Google Scholar 

  63. Axelrod FB. Hereditary sensory and autonomic neuropathies: familial dysautonomia and other HSANs. Clin Auton Res 2002; 12 Suppl 1:I2–I14.

    Article  PubMed  Google Scholar 

  64. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med 1997; 337:898–909.

    Article  CAS  PubMed  Google Scholar 

  65. Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007; 36:411–423.

    Article  CAS  PubMed  Google Scholar 

  66. Adams D. Hereditary and acquired amyloid neuropathies. J Neurol 2001; 248:647–657.

    Article  CAS  PubMed  Google Scholar 

  67. Masaki KH, Schatz IJ, Burchfiel CM, Sharp DS, Chiu D, Foley D, Curb JD. Orthostatic Hypotension Predicts Mortality in Elderly Men:The Honolulu Heart Program. Circulation 1998;98;2290–2295.

    CAS  PubMed  Google Scholar 

  68. Lahrmann H, Cortelli P, Hilz M et al. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol 2006;13:930–936.

    Article  CAS  PubMed  Google Scholar 

  69. Mathias CJ, Kimber JR. Treatment of postural hypotension. J Neurol Neurosurg Psychiatry 1998; 65:285–289.

    Article  CAS  PubMed  Google Scholar 

  70. Bannister R, Mathias CJ. Management of postural hypotension. In: Mathias CJ, Bannister R (eds). Autonomic Failure. A textbook of clinical disorders of the autonomic nervous system. Oxford: Oxford University Press; 1999:342–356.

    Google Scholar 

  71. Hoeldtke RD, Horvath GG, Bryner KD et al. Treatment of orthostatic hypotension with Midodrine and Octreotide. J Clin Endocrinol Metab 1998; 83:339–343.

    Article  CAS  PubMed  Google Scholar 

  72. Mathias CJ, Fosbraey P, De Costa DF Et al. Desmopressin reduces nocturnal polyuria, reverses overnight weight loss and improves morning postural hypotension in autonomic failure. Br Med J 1986; 293:353–354.

    Article  CAS  Google Scholar 

  73. Perera R, Isola L, Kauffmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in prinary autonomic failure. Clin Auton Res 1995; 5:211–214.

    Article  CAS  PubMed  Google Scholar 

  74. Schatz IJ, Bannister R, Freeman L et al. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res 1996; 6:125–126.

    Article  Google Scholar 

  75. Wieling W, Van Lieshout JJ, Van Leeuwen AM. Physical manoeuvres that reduce postural hypotension in autonomic failure. Clin Auton Res 1993; 3:57–65.

    Article  CAS  PubMed  Google Scholar 

  76. Omboni S, Smit AAJ, Van Lieshout JJ et al. Mechanism underlying the circadian variation in orthostatic tolerance in patients with autonomic failure. Clin Auton Res 1998; 5:274–275.

    Google Scholar 

  77. Van Lieshout JJ, Ten Harkel ADJ, Van Leeuwen AM et al.. Contrasting effects of acute and chronic volume expansion on orthostatic blood pressure control in a patient with autonomic circulatory failure. Neth J Med 1991; 39:72–83.

    PubMed  Google Scholar 

  78. Mathias CJ, Holly E, Armstrong E et al. The influence of food on postural hypotension in three groups with chronic autonomic failure:clinical and therapeutic implications. J Neurol Neurosurg Psychiatry 1991; 54:726–730.

    Article  CAS  PubMed  Google Scholar 

  79. Jordan J, Shannon JR, Black BK, et al. The pressor response to water drinking in humans:a sympathetic reflex? Circulation 2000;101:504–509.

    CAS  PubMed  Google Scholar 

  80. Ten Harkel ADJ, Van Lieshout JJ, Wieling W. Treatment of orthostatic hypotension with sleeping in the head up tilt position, alone and in combination with fludrocortisone. J Intern Med 1992; 232:139–145.

    Article  PubMed  Google Scholar 

  81. Smit AAJ, Hardjowijono MA, Wieling W. Are portable folding chairs useful to combat orthostatic hypotension? Ann Neurol 1997; 42:975–978.

    Article  CAS  PubMed  Google Scholar 

  82. Campbell IW, Ewing DJ, Clarke BF. 9-Alpha-?uorohydrocortisone in the treatment of postural hypotension in diabetic autonomic neuropathy. Diabetes 1975; 24:381–384.

    Article  CAS  PubMed  Google Scholar 

  83. Hoehn MM. Levodopa-induced postural hypotension. Treatment with udrocortisone. Archives of Neurology 1975; 32:50–51.

    CAS  PubMed  Google Scholar 

  84. Low PA, Gilden JL, Freeman R et al. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double blind multicenter study. J Am Med Assoc 1997; 277:1046–1051.

    Article  CAS  Google Scholar 

  85. Jankovic J, Gilden JL, Heine BC et al. Neurogenic orthostatic hypotension:a double blind, placebo controlled study with midodrine. Am J Med 1993; 95:38–48.

    Article  CAS  PubMed  Google Scholar 

  86. Wright RA, Kaufmann HC, Perera R, et al. A doubleblind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 1998; 51:120–124.

    CAS  PubMed  Google Scholar 

  87. Fouad-Tarazi FM, Okabe M, Goren H. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. Am J Med 1995;99:604–610.

    Article  CAS  PubMed  Google Scholar 

  88. Schrage WG, Eisenach JH, Dinenno FA, et al. Effects of midodrine on exercise-induced hypotension and blood pressure recovery in autonomic failure. Journal of Applied Physiology 2004; 97:1978–1984.

    Article  CAS  PubMed  Google Scholar 

  89. Akizawa T, Koshikawa S, Iida N, et al. Clinical effects of L-threo-3, 4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients. Nephron 2002; 90:384–390.

    Article  PubMed  Google Scholar 

  90. Iida N, Koshikawa S, Akizawa T, et al. Effects of Lthreo-3, 4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients. American Journal of Nephrology 2002; 22:338–346.

    Article  PubMed  Google Scholar 

  91. Carvalho MJ, van den Meiracker AH, Boomsma F, et al. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3, 4-dihydroxyphenylserine. Journal of the Autonomic Nervous System 1997; 62:63–71.

    Article  CAS  PubMed  Google Scholar 

  92. Freeman R, Landsberg L, Young J. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threodihydroxyphenylserine: a randomized, placebo-controlled, crossover trial. Neurology 1999; 53:2151–2157.

    CAS  PubMed  Google Scholar 

  93. Kaufmann H, Saadia D, Voustianiouk A, et al. Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation 2003; 108:724–728.

    Article  CAS  PubMed  Google Scholar 

  94. Mathias CJ, Senard JM, Braune S, et al. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension:a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clinical Autonomic Research 2001; 11:235–242.

    Article  CAS  PubMed  Google Scholar 

  95. Jordan J, Shannon JR, Biaggioni I et al. Contrasting actions of pressor agents in severe autonomic failure. Am J Med 1998; 105:116–124.

    Article  CAS  PubMed  Google Scholar 

  96. Shibao C, Gamboa A, Diedrich A et al. Acarbose, an alfa-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension 2007; 50:54–61.

    Article  CAS  PubMed  Google Scholar 

  97. Singer W, Sandroni P, Opfer-Gehrking TL, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol 2006; 63:513–518.

    Article  PubMed  Google Scholar 

  98. Shibao C, Gamboa A, Diedrich A et al. Management of Hypertension in the Setting of Autonomic Failure. A Pathophysiological Approach. Hypertension. 2005; 45:469–476.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Scienze Neurologiche, Università di Modena e Reggio Emilia, Italia

    Jessica Mandrioli

  2. Dipartimento di Scienze Neurologiche Clinica Neurologica, Università di Bologna, Bologna

    Pietro Cortelli

Authors
  1. Jessica Mandrioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pietro Cortelli
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Italia

About this chapter

Cite this chapter

Mandrioli, J., Cortelli, P. (2009). Patologie del sistema nervoso vegetativo. In: Terapia delle malattie neurologiche. Springer, Milano. https://doi.org/10.1007/978-88-470-1120-5_37

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-1120-5_37

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-88-470-1119-9

  • Online ISBN: 978-88-470-1120-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation